Colorimetric methods for rapid determination of pyrazinamide resistance

Colorimetric methods for rapid determination of pyrazinamide resistance

Background: Because pyrazinamide (PZA) is only effective for Mycobacterium tuberculosis at an acidic pH, susceptibility tests are more difficult to perform than those for other anti-tuberculosis (TB) drugs. The purpose of our work was to investigate the effectiveness of colorimetric methods to detec...

Full description

Bibliographic Details
Main Authors:	Ahmet Ugur Akbal, Belma Durupinar, Ahmet Yilmaz Coban
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	International Journal of Mycobacteriology
Subjects:	colorimetric nicotinamide pnca pyrazinamide tuberculosis
Online Access:	http://www.ijmyco.org/article.asp?issn=2212-5531;year=2020;volume=9;issue=3;spage=274;epage=280;aulast=Akbal

Similar Items

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China
by: Hui Xia, et al.
Published: (2020-01-01)

Analysis of pncA gene expression in pyrazinamide-resistant and multidrug-resistant <i>Mycobacterium tuberculosis</i>
by: Wang Nan，, Yang Yu, Deng Ling, Wu Hui, Liu Zhihui, Meng Fanrong
Published: (2023-12-01)

Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium tuberculosis from Henan Province
by: Shi J, et al.
Published: (2020-08-01)

The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide
by: Géraldine Daneau, et al.
Published: (2016-01-01)

Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Hunan, China
by: Liu B, et al.
Published: (2024-02-01)

‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility
by: Ying Zhang, et al.
Published: (2012-07-01)

Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis
by: Daniel Rueda, et al.
Published: (2018-01-01)

Next-generation sequencing to characterise pyrazinamide resistance in Mycobacterium tuberculosis isolates from two Balkan countries
by: Eva Sodja, et al.
Published: (2022-06-01)

Genetic Diversity and Drug Susceptibility Profiles of Multidrug-Resistant Tuberculosis Strains in Southeast China
by: Lin S, et al.
Published: (2021-09-01)

Detection of Mutations in <i>pncA</i> in <i>Mycobacterium tuberculosis</i> Clinical Isolates from Nepal in Association with Pyrazinamide Resistance
by: Dipti Shrestha, et al.
Published: (2022-09-01)

Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates<subtitle>PncA mutations and PZA resistance in M. tuberculosis in Vietnam</subtitle>
by: Nguyen Quang Huy, et al.
Published: (2017-01-01)

Exploring of pyrazinamidase recombinant activity from PZA-sensitive and resistant Mycobacterium tuberculosis expressed in Escherichia coli BL21 (DE3)
by: P. Purkan, et al.
Published: (2024-02-01)

Resistance To First-Line Antituberculosis Drugs And Prevalence Of pncA Mutations In Clinical Isolates Of Mycobacterium tuberculosis From Zunyi, Guizhou Province Of China
by: Cao Z, et al.
Published: (2019-09-01)

Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, China
by: Kun Li, et al.
Published: (2021-01-01)

Molecular Identification of Mutations Associated with Pyrazinamide-Resistance in Multidrug-Resistant Tuberculosis in Eight Provinces of Iran
by: Jila Moradi, et al.
Published: (2017-11-01)

Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China
by: Yang Che, et al.
Published: (2021-06-01)

Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan
by: Hsin-Ting Huang, et al.
Published: (2023-12-01)

The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors
by: Kyle H. Rohde, et al.
Published: (2021-01-01)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01)

Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis
by: Mikaela Glader, et al.
Published: (2015-01-01)

A multiple genome analysis of Mycobacterium tuberculosis reveals specific novel genes and mutations associated with pyrazinamide resistance
by: Patricia Sheen, et al.
Published: (2017-10-01)

Evaluation of four colourimetric susceptibility tests for the rapid detection of multidrug-resistant <italic>Mycobacterium tuberculosis</italic>isolates
by: Ahmet Yilmaz Coban, et al.
Published: (2015-08-01)

Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis
by: Shulan Dong, et al.
Published: (2024-01-01)

Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis
by: Shi D, et al.
Published: (2022-08-01)

Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study
by: M.J. Nasiri, et al.
Published: (2021-07-01)

PYRAZINAMIDE/PYRAZINOIC ACID RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS: RECENT FINDINGS AND IMPLICATIONS FOR IMPROVING THE TREATMENT OF TUBERCULOSIS
by: R. M. Anthony, et al.
Published: (2018-12-01)

Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis
by: Manijeh Kahbazi, et al.
Published: (2018-04-01)

Resistance to pyrazinamide in Mycobacterium tuberculosis complex isolates from previously treated tuberculosis cases in Southwestern Oromia, Ethiopia
by: Getu Balay, et al.
Published: (2024-02-01)

Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M. tuberculosis
by: Jiayun Liu, et al.
Published: (2019-02-01)

pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia
by: Salim Allana, et al.
Published: (2017-03-01)

Assessment of adherence to antituberculosis drug regimen among patients receiving isoniazid, rifampin and pyrazinamide: Kerman, Iran
by: Seyyed Mojtaba Sohrevardi, et al.
Published: (2019-07-01)

A novel inexpensive electrochemical sensor for pyrazinoic acid as a potential tool for the identification of pyrazinamide-resistant Mycobacterium tuberculosis
by: Daniel Rueda, et al.
Published: (2018-01-01)

DEVELOPMENT OF DERIVATIVE SPECTROPHOTOMETRIC METHOD FOR SIMULTANEOUS DETERMINATION OF PYRAZINAMIDE AND RIFAMPICIN IN CUBOSOME FORMULATION
by: Morgana Souza Marques, et al.
Published: (2021-06-01)

New insights into the mechanism of action of pyrazinamide, implications for susceptibility testing, and future regimens*
by: Richard M Anthony, et al.
Published: (2016-01-01)

The impact of inclusion, dose and duration of pyrazinamide (PZA) on efficacy and safety outcomes in tuberculosis: systematic review and meta-analysis protocol
by: James D. Millard, et al.
Published: (2019-12-01)

Pyrazinamide-induced phototoxicity: A case report and review of literature
by: Katiyar Subodh, et al.
Published: (2010-01-01)

Contributions to the diagnosis of pirazinamide resistance in Mycobacterium tuberculosis
by: Ernesto Montoro, et al.
Published: (2011-12-01)

Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide in patients with pulmonary tuberculosis
by: Mônica C. Façanha, et al.

Pyrazinamide-induced maculopapular rash
by: Khayyam Khalid, et al.
Published: (2010-01-01)

Nigella sativa can Cure Hepatotoxicity Caused by Pyrazinamide Administration; A Lead from Animal Experiment
by: Amtul Hafeez, et al.
Published: (2020-12-01)